LBA91 TOMAS2: A Randomized Phase II Study from the Italian Sarcoma Group (ISG) of Trabectedin Plus Olaparib (T+O) or Trabectedin (T) in Advanced, Metastatic, or Unresectable Soft Tissue Sarcomas (STS) after Failure of Standard Treatments

Annals of Oncology(2023)

引用 0|浏览21
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要